These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [Beta 2-microglobulin--its role in renal failure and hemodialysis therapy]. Czyz W; Szepietowski T Postepy Hig Med Dosw; 1992; 46(2):209-38. PubMed ID: 1470582 [TBL] [Abstract][Full Text] [Related]
11. [What is the reason for the increase in beta-2-microglobulin levels in the blood when using cuprophane dialysis membranes?]. Sulková S; Lapcík O; Votruba T Cas Lek Cesk; 1989 Apr; 128(17):520-3. PubMed ID: 2665936 [TBL] [Abstract][Full Text] [Related]
12. [Changes in the beta 2-microglobulin level during hemodialysis]. Nikitinskaia LP; Stetsiuk EA; Iarmolinskiĭ IS; Barinov AV; Kon'kova TA Urol Nefrol (Mosk); 1990; (5):29-31. PubMed ID: 2264202 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance of a dialysis membrane that can remove beta 2-microglobulin (beta 2m). Ono T; Iwamoto N; Kataoka H; Yamada S; Sakai Y; Kunitomo T ASAIO Trans; 1988; 34(3):342-5. PubMed ID: 3058179 [TBL] [Abstract][Full Text] [Related]
14. Silicon in chronic hemodialysis patients. Hosokawa S; Morinaga M; Nishitani H; Maeda T; Yoshida O ASAIO Trans; 1987; 33(3):260-4. PubMed ID: 3314921 [No Abstract] [Full Text] [Related]
15. Progression of residual renal function with an increase in dialysis: haemodialysis versus peritoneal dialysis. Teruel-Briones JL; Fernández-Lucas M; Rivera-Gorrin M; Ruiz-Roso G; Díaz-Domínguez M; Rodríguez-Mendiola N; Quereda-Rodríguez-Navarro C Nefrologia; 2013; 33(5):640-9. PubMed ID: 24089155 [TBL] [Abstract][Full Text] [Related]